Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
Clinical trial NCT00235391 · COMPLETED
Trial details
- NCT number
- NCT00235391
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-10-01
- Enrollment
- 1683
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.